4.6 Article

Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Status update in the use of cell-penetrating peptides for the delivery of macromolecular therapeutics

Kaido Kurrikoff et al.

Summary: This review highlights recent advancements and applications of cell-penetrating peptides (CPP) in delivering macromolecular therapeutics. Significant progress has been made in clinical development of CPP-drug conjugates targeting protein-protein interactions, particularly in the treatment of cancer. Other areas of interest include antisense oligonucleotides, muscular dystrophies, lung targeting, and trans-BBB targeting.

EXPERT OPINION ON BIOLOGICAL THERAPY (2021)

Review Biochemistry & Molecular Biology

Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing

Britt Hanson et al.

Summary: Duchenne muscular dystrophy (DMD) is an incurable genetic muscle disorder characterized by muscle wasting and premature death, with therapeutic approaches including antisense oligonucleotide-mediated splice modulation and gene editing. Progress has been made in the treatment of DMD, but challenges and limitations remain in clinical translation.

RNA BIOLOGY (2021)

Article Chemistry, Multidisciplinary

Novel Lipid-Oligonucleotide Conjugates Containing Long-Chain Sulfonyl Phosphoramidate Groups: Synthesis and Biological Properties

Alina Derzhalova et al.

Summary: Novel lipid-conjugated DNA and RNA derivatives with low cytotoxicity and efficient cellular uptake without transfection agents were synthesized. Lipid-conjugated siRNAs targeting RGMa showed comparable gene silencing activity to unmodified control siRNA when delivered into cells via Lipofectamine-mediated transfection.

APPLIED SCIENCES-BASEL (2021)

Review Medicine, General & Internal

Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy

Fernanda Fortunato et al.

Summary: Duchenne muscular dystrophy is a common childhood muscle disease affecting males, with therapeutic advances targeting the dystrophin protein showing promise in treating the condition. Research into molecular pathways affected in DMD has resulted in the development of approved orphan drugs and promising gene therapy approaches.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Medicine, Research & Experimental

Delivery of oligonucleotide-based therapeutics: challenges and opportunities

Suzan M. Hammond et al.

Summary: The field of nucleic acid-based therapeutics has seen rapid development in recent years, with the main challenge being delivery to target tissues. The adoption of delivery technologies, such as conjugates or nanoparticles, has been a game changer for many therapeutic indications.

EMBO MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays

Zhichao Tang et al.

Summary: RNA splicing is crucial in producing mature mRNA, and leveraging splicing modifiers as a pharmacological modality shows promising potential in treating diseases caused by aberrant splicing. Approved drugs include antisense oligonucleotide splicing modifiers and a small-molecule splicing modifier risdiplam, targeting mRNA precursors.

MOLECULES (2021)

Review Clinical Neurology

Restorative treatments of dystrophin expression in Duchenne muscular dystrophy: A systematic review

Carlos Pascual-Morena et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Review Biotechnology & Applied Microbiology

Advances in oligonucleotide drug delivery

Thomas C. Roberts et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Review Biochemistry & Molecular Biology

Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules

Manuel Hawner et al.

MOLECULES (2020)

Review Biochemistry & Molecular Biology

Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides

Yanfeng Wang et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)

Article Biochemistry & Molecular Biology

Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle

Thazha P. Prakash et al.

NUCLEIC ACIDS RESEARCH (2019)

Review Pharmacology & Pharmacy

Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy

Jean-Francois Goossens et al.

PHARMACOLOGY & THERAPEUTICS (2019)

Article Biochemistry & Molecular Biology

Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells

Shiyu Wang et al.

NUCLEIC ACID THERAPEUTICS (2019)

Article Medicine, General & Internal

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease

J. Kim et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Biochemistry & Molecular Biology

GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics

Aaron D. Springer et al.

NUCLEIC ACID THERAPEUTICS (2018)

Review Biochemistry & Molecular Biology

Improving Small Interfering RNA Delivery In Vivo Through Lipid Conjugation

Maire F. Osborn et al.

NUCLEIC ACID THERAPEUTICS (2018)

Article Chemistry, Medicinal

Saponins enhance exon skipping of 2′-O-methyl phosphorothioate oligonucleotide in vitro and in vivo

Mingxing Wang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2018)

Review Pharmacology & Pharmacy

Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles

Nebojsa Pavlovic et al.

FRONTIERS IN PHARMACOLOGY (2018)

Article Biochemical Research Methods

Stability of Oligonucleotide-Small Molecule Conjugates to DNA-Deprotection Conditions

Lik Hang Yuen et al.

BIOCONJUGATE CHEMISTRY (2017)

Review Medicine, Research & Experimental

Delivery is key: lessons learnt from developing splice-switching antisense therapies

Caroline Godfrey et al.

EMBO MOLECULAR MEDICINE (2017)

Review Pharmacology & Pharmacy

Bile acids and bile acid derivatives: use in drug delivery systems and as therapeutic agents

Celia Faustino et al.

EXPERT OPINION ON DRUG DELIVERY (2016)

Article Biochemistry & Molecular Biology

The delivery of therapeutic oligonucleotides

Rudolph L. Juliano

NUCLEIC ACIDS RESEARCH (2016)

Review Chemistry, Multidisciplinary

Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics

Cornelia Lorenzer et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Article Chemistry, Multidisciplinary

Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing

Jayaprakash K. Nair et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)

Review Pharmacology & Pharmacy

Current progress on aptamer-targeted oligonucleotide therapeutics

Justin P. Dassie et al.

THERAPEUTIC DELIVERY (2013)

Review Pharmacology & Pharmacy

Intracellular delivery of RNA-based therapeutics using aptamers

Kristina W. Thiel et al.

THERAPEUTIC DELIVERY (2010)

Article Biotechnology & Applied Microbiology

Efficient in vivo delivery of siRNA to the liver by conjugation of α-tocopherol

Kazutaka Nishina et al.

MOLECULAR THERAPY (2008)

Article Medicine, General & Internal

Local dystrophin restoration with antisense oligonucleotide PRO051

Judith C. van Deutekom et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Biotechnology & Applied Microbiology

Mechanisms and optimization of in vivo delivery of lipophilic siRNAs

Christian Wolfrum et al.

NATURE BIOTECHNOLOGY (2007)

Article Chemistry, Organic

3′-Oligonucleotides conjugation via chemoselective oxime bond formation

D Forget et al.

TETRAHEDRON LETTERS (2001)

Article Biochemical Research Methods

A convenient solid-phase method for synthesis of 3′-conjugates of oligonucleotides

DA Stetsenko et al.

BIOCONJUGATE CHEMISTRY (2001)

Article Biochemistry & Molecular Biology

Synthesis and properties of bile acid phosphoramidites 5′-tethered to antisense oligodeoxynucleotides against HCV

TJ Lehmann et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2001)